• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2025, Vol. 27 ›› Issue (6): 565-570.

• 专栏:药物临床试验 • 上一篇    下一篇

新政策背景下地市级医院药物临床试验质量管理体系优化研究

王翠12, 郑建中2   

  1. 1.山西医科大学附属运城市中心医院,山西 运城 044000;
    2.山西医科大学公共卫生学院,山西 太原 030000
  • 收稿日期:2024-11-04 修回日期:2025-03-05 接受日期:2025-03-14 出版日期:2025-06-28 发布日期:2025-08-06
  • 基金资助:
    山西省高等学校哲学社会科学项目(2020W047)

Optimization of Drug Clinical Trial Quality Management System in Municipal Hospitals Under the Background of the New Policy

WANG Cui12, ZHENG Jianzhong2   

  1. 1.Yuncheng Central Hospital Affiliated to Shanxi Medical UniversityShanxi Yuncheng 044000,China
    2.School of Public Health Shanxi Medical UniversityShanxi Taiyuan 030000, China
  • Received:2024-11-04 Revised:2025-03-05 Accepted:2025-03-14 Online:2025-06-28 Published:2025-08-06

摘要:

目的:探讨优化临床试验质量管理体系的新举措新方法,持续改进临床试验质量,保护受试者的权益和安全。方法:运用头脑风暴法、鱼骨图、PDCA循环等管理工具对某地市级医院药物临床试验机构临床试验质控问题进行归类汇总,从研究机构、研究者、申办者、受试者等多角度分析原因,在体系建设、责任落实、能力提升、过程管理等方面制定相应的制度体系和干预措施。结果:通过优化临床试验质量管理体系建设,该院临床试验质量显著提升,缺陷发生率整体下降,其中受试者筛选入组、安全性事件管理、临床试验源文件及数据记录、试验用药品管理等不规范问题发生率均有所下降。结论:新政策背景下,药物临床试验机构应通过压实主要研究者责任,严格履职能力考核;强化研究者能力提升,规范GCP质量考核;优化质控管理制度,健全风险管理模式等措施,全面保障临床试验质量。

  

关键词: 临床试验, 质量管理, PDCA循环, 风险管理, 优化研究

Abstract:

Objective: To explore innovative measures and methods to optimize the clinical trial quality management system in order to achieve continuous improvement in the quality of clinical trials safeguard the rights and safety of participants.Methods: Management tools such as brainstorming sessions fishbone diagrams and PDCA Plan-Do-Check-Act cycles were employed to classify and summarize issues related to clinical trial quality control in a drug clinical trial institution of a municipal-level hospital. The study analyzed root causes of the problem from multiple perspectives including research institutions researcherssponsors and subjects. Corresponding systems and intervention strategies were developed focusing on system construction accountability implementation capability enhancement and process management.Results: By optimizing the clinical trial quality management system the quality of clinical trials in this hospital has significantly improved and the overal incidence of abnormal problems-such as subject screening errorssafety event management deficiencies inadequacies in source documentation/data recording practices and experimental drug management was notably reduced.Conclusion: In light of new policy developments drug clinical trial institutions should enhance their quality management systems by reinforcing accountability and performance assessments among principal investigators improving researcher capabilities while standardizing Good Clinical Practice GCP evaluations refining the overall quality control framework and perfecting risk management models to comprehensively ensure the quality of clinical trials.

 

Key words: Clinical trials , Quality management , PDCA cycle , Risk management , Optimization

中图分类号: